Shemesh Shay 4
4 · Nuvectis Pharma, Inc. · Filed Sep 27, 2022
Insider Transaction Report
Form 4
Shemesh Shay
Chief Dev. & Ops. Officer
Transactions
- Purchase
Common Stock
2022-09-23$7.87/sh+220$1,731→ 1,245,065 total
Footnotes (1)
- [F1]Includes 48,399 shares of restricted stock and 60,000 restricted stock units.